Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

Nature, Published online: 04 March 2026; doi:10.1038/s41586-026-10197-0

Germline and somatic interactions define actionable genomic patterns driving acquired therapy resistance in breast cancer.